The few published studies on the relationship between Helicobacter pylori infection and metabolic homeostasis were relatively small and yielded inconsistent results. We examined the prevalence of metabolic syndrome in relation to H. pylori infection and its symptoms in a large and unselected population. Coded data from the computerised database of a large health maintenance organisation in Israel were accessed for 147,936 individuals 25-95 years of age who performed the urea breath test during 2002-2012. The classification of metabolic syndrome followed a modified definition of the international diabetes federation. Prevalences of H. pylori infection and metabolic syndrome were 52.0% and 11.4% respectively. H. pylori infected patients had increased likelihood of metabolic syndrome: adjusted odds ratio (aOR) 1.15 (95% confidence intervals (CI) 1.10-1.19) , as did patients with gastric ulcer: aOR 1.15 (95% CI 1.03-1.28) vs patients without these conditions. Duodenal ulcer was associated with metabolic syndrome only in persons aged 25-34 years: aOR 1.59 (95% CI 1.19-2.13), but not in older persons (P = 0.001 for heterogeneity). In conclusion, the likelihood of metabolic syndrome appeared significantly increased in relation to H. pylori infection and gastric and duodenal ulcers. These findings suggest that H. pylori long-term gastric inflammation might play a role in metabolic homeostasis.
The prevalence of metabolic syndrome according to H. pylori infection, and gastric and duodenal ulcers. Overall, metabolic syndrome prevalence was slightly higher in H. pylori positive (by UBT) than negative persons (P < 0.001), but the difference was of greater magnitude in patients who had gastric and duodenal ulcers compared to those without a diagnosis code of these illnesses ( Table 2) . Adjusting for age resulted in strengthening the relationship of H. pylori with the metabolic syndrome, and attenuating the relationships of both gastric and duodenal ulcers with the metabolic syndrome.
Stratification by age groups showed higher prevalences of metabolic syndrome in people with H. pylori infection, gastric ulcer or duodenal ulcer compared to people without these conditions in most age groups (Table 3) .
Pooled and age-stratified multivariable analyses were fitted. The pooled analyses showed that H. pylori infected persons had significantly increased likelihood of metabolic syndrome compared to uninfected patients; adjusted odds ratio (aOR) 1.15 [95% CI 1.10-1.19]). The strength of association between gastric ulcer and metabolic syndrome was weakened following adjustment for age, country of birth and residential economic rank 
Discussion
We examined the prevalence of metabolic syndrome in relation to H. pylori infection and peptic ulcers. Overall, H. pylori infected persons had higher prevalence of metabolic syndrome than uninfected ones. Similarly, a positive association was found between gastric ulcer and the metabolic syndrome. The strength of these associations was modest. The associations of duodenal ulcer was significantly modified by age, showing significantly 1.59-fold increased likelihood to have metabolic syndrome, in patients with versus without this condition, only in the age group 25-34 years. Collectively these findings suggest complex relationships between infection with H. pylori infection and the metabolic syndrome, as well as of gastric and duodenal ulcers with the metabolic syndrome. Sociodemographic confounders appear to explain such associations only partially, thus suggesting that H. pylori might have an independent and specific role in the metabolic syndrome. A limited number of investigations have assessed the prevalence of the metabolic syndrome according to infection with H. pylori [11] [12] [13] [14] [15] [16] [17] [18] . Mostly, they were conducted in East Asia 11, 12, 14, [16] [17] [18] and two studies were undertaken in Middle Eastern countries (Lebanon and Iran) 13, 15 . Except for Naja et al. 13 , all the studies demonstrated significantly higher prevalence of the metabolic syndrome in persons infected with H. pylori compared to uninfected ones 11, 12, [14] [15] [16] [17] [18] . The sample size in these studies ranged from 308 to 7394 persons. They employed various detection techniques of H. pylori and various classification criteria for the metabolic syndrome. Most of these studies reported results from adjusted models. A recent meta-analysis combining results from these studies 19 yielded a pooled OR of 1.34 (95% CI 1.17-1.53), with significant heterogeneity across the studies 19 . Our study provides the largest sample size to date, in which we used a uniform classification of both the exposure and outcome variables, as well as adjusted for possible confounders. The magnitude of the association in our study was modest with an aOR of 1.15 (95% CI 1.1-1.19). A similar association was found in relation to gastric ulcer, while duodenal ulcer showed a stronger association in the age group 25-34 years. These illnesses are caused by H. pylori through persistent gastric inflammation induced by the bacterium 5 . Our observations are in agreement with findings reported by Chen et al. 17 , who demonstrated significantly increased likelihood of the metabolic syndrome in persons positive versus negative for H. pylori IgG serum antibody in young adults, although the magnitude of association in our study is much smaller. Shin et al. have shown 14 a stronger association between H. pylori infection with metabolic syndrome, if the infection status was determined based on histology, but they found no significant association when using serological assay. Collectively, these and our findings suggest that H. pylori infected persons had higher prevalence of metabolic syndrome than uninfected ones. The association between gastroduodenal disease and the metabolic syndrome might suggest that more severe gastric inflammation might be involved in metabolic imbalance. Indeed, it was shown that H. pylori infection, and eradication of the infection, can alter ghrelin and leptin levels 20, 21 (reviewed by Haj et al. 4 ), two hormones expressed in the stomach and involved in metabolic homoeostasis 22, 23 . Additionally, it is possible that the long-term gastric inflammation might enhance the pro-inflammatory state related to metabolic syndrome.
Given the cross-sectional study design, we cannot determine whether observed associations are causal; nonetheless, they are of public health importance, as H. pylori infection and peptic diseases might serve as markers to identify patients with increased likelihood for metabolic syndrome. The interaction between age and peptic ulcer might be due to poorer survival of old symptomatic H. pylori infected patients, compared to survivors who were included in the cohort. Limitations of our study should be acknowledged. Electronic health and demographic data from a health maintenance organisation (HMO) database were utilized. These data accumulate as part of patients' care; specifically, in our study, in regard to patients who were referred to UBT by their physicians. Thus, our sample represents patients with gastrointestinal symptoms. Data collection on variables such as BMI and smoking might be different in the various clinics across the country. Other than smoking, information was missing in low percentages for such confounders as country of birth, socioeconomic status and BMI. Importantly, the study database lacks information on waist circumference; a surrogate marker of central obesity, therefore, we used obesity (BMI ≥30 kg/ m 2 ) as a proxy for central obesity. The cutoffs of waist circumference of 102 cm and 88 cm for men and women, respectively, are associated with increased risk of cardiovascular diseases, and they were driven by correlation with BMI >30 ( 24 , reviewed in 25 ). BMI and waist circumference are strongly correlated with correlations coefficients ranging from 0.80 to 0.95 26 . Therefore, if misclassification of metabolic syndrome exists, because of using BMI ≥30 kg/m 2 as a proxy for central obesity, it is expected to be non-differential, thus suggesting that our findings are conservative.
In addition, non-differential misclassification of gastric ulcer and duodenal ulcer might have occurred since the presence of these conditions was determined based on diagnostic codes in medical records. Diagnosis code of peptic ulcers disease showed a high positive predictive value of >90% 27, 28 . Such misclassification might have led the measure of association towards the null hypothesis.
Strengths of our study include using UBT results to determine the presence of H. pylori infection. UBT is highly sensitive and specific for H. pylori identification compared to gold standard tests 29 . The study sample size was very large, which allowed identification of a relatively modest association between infection with H. pylori and metabolic syndrome prevalence, with effect modification by age. In addition, the definition of diabetes mellitus 30 and hypertension 31 relied on the same criteria throughout the study period. These definitions combine physicians' diagnoses, results of blood biochemical analyses (e.g., fasting blood glucose and glycated haemoglobin in diabetes), buying medications to treat these conditions (antidiabetic and blood lowering agents), and several blood pressure measurements. Moreover, a standard definition was employed for the metabolic syndrome. Lastly, all laboratory tests were performed in one laboratory during the study period.
In conclusion, persons infected with H. pylori and those with peptic ulcer disease have significantly higher likelihood of the metabolic syndrome compared to persons without these conditions. These findings suggest that H. pylori long-term gastric inflammation might play a role in metabolic homeostasis.
Methods
Study design and population. A prevalence study was undertaken employing health and demographic information obtained from the computerised database of Maccabi Health Services (MHS) HMO. MHS is ranked as the second largest HMO in Israel, insuring about two million people, i.e., about one-quarter of the population. The study cohort has been described in detail 32 (within two years of the UBT) and documented purchase of anti-H. pylori therapy or proton pump inhibitors within one month of the UBT were excluded from the study.
Definitions of the study variables. Sociodemographic data were collected on patients' age (grouped as 25-34, 35-44, 45-54 , 65-95 years), sex, town of residence and country of birth (grouped as Israel, North Africa/ Asia, Former Soviet Unions, Europe/Americas and other). The definition of socioeconomic status relied on residential economic rank; i.e. of town of residence 33 . This aggregative index reflects certain features of a specific geographical area, including income, housing, cars (i.e. motorization level), education and employment 33 . Persons living in towns with residential economic ranks of 1-5 were categorised as living in low socioeconomic areas, and those living in towns with 6-7 and 8-10 socioeconomic ranks were categorised as living in intermediate and high socioeconomic areas, respectively.
Persons with a UBT result >3.5 per thousand were classified as infected with H. pylori, and those having lower UBT results were classified as negatives or uninfected. The international Classification of Disease codes-9 th revision with clinical modifications (ICD-9) was employed to determine whether patients had gastric ulcer or duodenal ulcers.
Data were collected on smoking (categorised as never smoked, ever smokers, and smoking status unknown) and on BMI, which is calculated as weight in kilograms (kg)/height 2 in meters (m)).
Laboratory results were obtained on triglycerides, high-density lipoproteins (HDL), and fasting plasma glucose levels. Data on purchasing statins and anti-diabetic medications was also retrieved. A modified classification of the International Diabetes Federation 1,34 was employed to identify persons with metabolic syndrome. Obesity defined as BMI ≥30 kg/m 2 was used as a proxy for central obesity given the lack of information on waist circumference. Obesity in addition to two or more of the following criteria defined metabolic syndrome: raised triglycerides (>150 mg/dL or statins use); low HDL levels (<40 mg/dL in men and <50 mg/dL in women), hypertension (defined based on MHS registry 31 ); or raised plasma glucose levels (≥100 mg/dL or a diagnosis of diabetes based on MHS registry 30 ).
Statistical analysis. Differences in sociodemographic factors between patients with and without informa-
tion on at least one parameter of metabolic syndrome (beyond BMI) were examined using chi square test. Patients who had information on metabolic syndrome parameters differed significantly in sociodemographic variables compared to patients lacking such information ( Supplementary Table 1 ), therefore we used inverse probability weighting method 35 , where the weights were assigned as the inverse probability obtained from multiple logistic regression model predicting having information on metabolic syndrome parameters.
Differences in the prevalence of the metabolic syndrome according to sociodemographic variables, H. pylori infection and its related gastroduodenal diseases were examined by chi square test. Age-adjusted associations between the infection and metabolic syndrome were examined using Cochran's Mantel-Haenszel test.
Using Generalized Estimating Equations we examined adjusted relationships of H. pylori infection (determined as UBT result >3.5), gastric ulcer and duodenal ulcer with metabolic syndrome, while adjusting for sociodemographic factors. Adjusted ORs (and 95% confidence intervals [CIs]) were obtained from these models. Pooled and aged stratified analyses were performed. Heterogeneity across age groups was assessed using the chi square test for heterogeneity. The significance level was determined as two-sided P < 0.05. Analysis of data was performed using IBM-SPSS version 23 (IBM, Armonk, New York, USA) and Winpepi 36 .
Ethical consideration. Ethical approval was obtained from the institutional review board (IRB) (Helsinki committee) of Assuta Medical Centre and from the ethics committee of Tel Aviv University. An exempt from informed consent was granted due to the retrospective study design and the use of de-identified data (anonymized) from medical files. The study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki.
